1. Home
  2. VEON vs TLX Comparison

VEON vs TLX Comparison

Compare VEON & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VEON Ltd. ADS

VEON

VEON Ltd. ADS

HOLD

Current Price

$51.68

Market Cap

3.8B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$10.45

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VEON
TLX
Founded
1992
2015
Country
United Arab Emirates
Australia
Employees
N/A
1184
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.6B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VEON
TLX
Price
$51.68
$10.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$73.40
$21.13
AVG Volume (30 Days)
79.2K
181.0K
Earning Date
05-13-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$12.21
N/A
Revenue Next Year
$1.60
N/A
P/E Ratio
$6.15
$150.33
Revenue Growth
N/A
N/A
52 Week Low
$42.60
$6.28
52 Week High
$64.00
$16.85

Technical Indicators

Market Signals
Indicator
VEON
TLX
Relative Strength Index (RSI) 47.46 44.54
Support Level $51.71 $10.06
Resistance Level $55.39 $11.38
Average True Range (ATR) 1.54 0.28
MACD -0.05 -0.14
Stochastic Oscillator 23.44 13.12

Price Performance

Historical Comparison
VEON
TLX

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan. Its telecommunications and digital services include voice, fixed broadband, data and cloud services.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: